Science & Technology
Development of a treatment for durable remission of HIV using transposon engineered CAR-T and NK cells
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R41AI170186-01A1
Award Ceiling
$307K
Award Floor
$307K
Close Date
Nov 30, 2023
Total Funding
$307K
Expected Awards
1
Posted Date
Dec 7, 2022
Cost Sharing Required
No
Grants.gov ID
sbir-1R41AI170186-01A1
Description
STTR Phase Phase I award: "Development of a treatment for durable remission of HIV using transposon engineered CAR-T and NK cells" awarded to MARPAM PHARMA LLC in LANDFALL VILLAGE, Minnesota. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $306,500. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.